{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T07:56:46Z","timestamp":1791619006865,"version":"4.3.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T00:00:00Z","timestamp":1599177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T00:00:00Z","timestamp":1599177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"China Postdoctoral Fund Project","award":["2018M632780"],"award-info":[{"award-number":["2018M632780"]}]},{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["182300410349"],"award-info":[{"award-number":["182300410349"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministry of Science and Technology National Key Research and Development Program","award":["12230041114"],"award-info":[{"award-number":["12230041114"]}]},{"name":"Joint Construction Project of Henan Provincial Health Committee and Ministry of Health","award":["201701017"],"award-info":[{"award-number":["201701017"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objectives<\/jats:title><jats:p>A role for the type II arginine methyltransferase PRMT5 in various human diseases has been identified. In this study, the potential mechanism underlying the involvement of PRMT5 in the pathological process leading to osteoarthritis (OA) was investigated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>PRMT5 expression in cartilage tissues from patients with OA and control individuals was assessed by immunohistochemical staining. The regulatory and functional roles of PRMT5 in the chondrocytes of patients with OA and control individuals were determined by western blotting and reverse transcription polymerase chain reaction. The effects of the PRMT5 inhibitor EPZ on interleukin-1\u03b2-induced inflammation were examined in the chondrocytes of patients with OA and in the destabilized medial meniscus (DMM) of a mouse model of OA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>PRMT5 was specifically upregulated in the cartilage of patients with OA. Moreover, adenovirus-mediated overexpression of PRMT5 in human chondrocytes caused cartilage degeneration. This degeneration was induced by elevated expression levels of matrix-degrading enzymes (matrix metalloproteinase-3 (MMP-3) and matrix metalloproteinase-13 (MMP-13)) in chondrocytes. The activation of the MAPK and nuclear factor \u03baB signaling pathways was evidenced by elevated levels of p-p65, p-p38, and p-JNK. These effects were attenuated by inhibiting the expression of PRMT5. In the mouse model, EPZ inhibited PRMT5 expression, thus protecting mouse cartilage from DMM-induced OA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our results demonstrate that PRMT5 is a crucial regulator of OA pathogenesis, implying that EPZ has therapeutic value in the treatment of this cartilage-destroying disease.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13075-020-02304-x","type":"journal-article","created":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T11:02:57Z","timestamp":1599217377000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["PRMT5 inhibition attenuates cartilage degradation by reducing MAPK and NF-\u03baB signaling"],"prefix":"10.1186","volume":"22","author":[{"given":"Yonghui","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongguang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jincheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipeng","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0248-4307","authenticated-orcid":false,"given":"Jia","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,4]]},"reference":[{"key":"2304_CR1","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrrheum.2014.44","volume":"10","author":"DJ Hunter","year":"2014","unstructured":"Hunter DJ, Schofield D, Callander E. The individual and socioeconomic impact of osteoarthritis. Nat Rev Rheumatol. 2014;10:437\u201341.","journal-title":"Nat Rev Rheumatol"},{"key":"2304_CR2","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/S0140-6736(19)30417-9","volume":"393","author":"DJ Hunter","year":"2019","unstructured":"Hunter DJ, Bierma-Zeinstra S. Osteoarthritis. Lancet. 2019;393:1745\u201359.","journal-title":"Lancet."},{"key":"2304_CR3","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0140-6736(14)60802-3","volume":"386","author":"S Glyn-Jones","year":"2015","unstructured":"Glyn-Jones S, Palmer AJ, Agricola R, Price AJ, Vincent TL, Weinans H, et al. Osteoarthritis. Lancet. 2015;386:376\u201387.","journal-title":"Lancet."},{"key":"2304_CR4","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/art.22337","volume":"56","author":"AB Blom","year":"2007","unstructured":"Blom AB, van Lent PL, Libregts S, Holthuysen AE, van der Kraan PM, van Rooijen N, et al. Crucial role of macrophages in matrix metalloproteinase-mediated cartilage destruction during experimental osteoarthritis: involvement of matrix metalloproteinase 3. Arthritis Rheum. 2007;56:147\u201357.","journal-title":"Arthritis Rheum"},{"key":"2304_CR5","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/1529-0131(200103)44:3<585::AID-ANR107>3.0.CO;2-C","volume":"44","author":"LC Tetlow","year":"2001","unstructured":"Tetlow LC, Adlam DJ, Woolley DE. Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes. Arthritis Rheum. 2001;44:585\u201394.","journal-title":"Arthritis Rheum"},{"key":"2304_CR6","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/s13075-017-1454-2","volume":"19","author":"H Li","year":"2017","unstructured":"Li H, Wang D, Yuan Y, Min J. New insights on the MMP-13 regulatory network in the pathogenesis of early osteoarthritis. Arthritis Res Ther. 2017;19:248.","journal-title":"Arthritis Res Ther."},{"key":"2304_CR7","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/art.20776","volume":"52","author":"M Kobayashi","year":"2005","unstructured":"Kobayashi M, Squires GR, Mousa A, Tanzer M, Zukor DJ, Antoniou J, et al. Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage. Arthritis Rheum. 2005;52:128\u201335.","journal-title":"Arthritis Rheum"},{"key":"2304_CR8","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2741\/1817","volume":"11","author":"PS Burrage","year":"2006","unstructured":"Burrage PS, Mix KS, Brinckerhoff CE. Matrix metalloproteinases: role in arthritis. Front Biosci. 2006;11:529\u201343.","journal-title":"Front Biosci"},{"key":"2304_CR9","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3389\/fphar.2018.00365","volume":"9","author":"MK Shanmugam","year":"2018","unstructured":"Shanmugam MK, Ahn KS, Lee JH, Kannaiyan R, Mustafa N, Manu KA, et al. Celastrol attenuates the invasion and migration and augments the anticancer effects of bortezomib in a xenograft mouse model of multiple myeloma. Front Pharmacol. 2018;9:365.","journal-title":"Front Pharmacol"},{"key":"2304_CR10","first-page":"2571","volume":"2014","author":"L Nissinen","year":"1840","unstructured":"Nissinen L, Kahari VM. Matrix metalloproteinases in inflammation. Biochim Biophys Acta. 1840;2014:2571\u201380.","journal-title":"Biochim Biophys Acta"},{"key":"2304_CR11","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.3389\/fphar.2018.01378","volume":"9","author":"S Liang","year":"2018","unstructured":"Liang S, Lv ZT, Zhang JM, Wang YT, Dong YH, Wang ZG, et al. Necrostatin-1 attenuates trauma-induced mouse osteoarthritis and IL-1\u03b2 induced apoptosis via HMGB1\/TLR4\/SDF-1 in primary mouse chondrocytes. Front Pharmacol. 2018;9:1378.","journal-title":"Front Pharmacol"},{"key":"2304_CR12","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1038\/ncb1802","volume":"10","author":"M Jansson","year":"2008","unstructured":"Jansson M, Durant ST, Cho EC, Sheahan S, Edelmann M, Kessler B, et al. Arginine methylation regulates the p53 response. Nat Cell Biol. 2008;10:1431\u20139.","journal-title":"Nat Cell Biol"},{"key":"2304_CR13","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.pharmthera.2006.06.007","volume":"113","author":"CD Krause","year":"2007","unstructured":"Krause CD, Yang ZH, Kim YS, Lee JH, Cook JR, Pestka S. Protein arginine methyltransferases: evolution and assessment of their pharmacological and therapeutic potential. Pharmacol Ther. 2007;113:50\u201387.","journal-title":"Pharmacol Ther"},{"key":"2304_CR14","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/onc.2016.199","volume":"36","author":"YK Banasavadi-Siddegowda","year":"2017","unstructured":"Banasavadi-Siddegowda YK, Russell L, Frair E, Karkhanis VA, Relation T, Yoo JY, et al. PRMT5-PTEN molecular pathway regulates senescence and self-renewal of primary glioblastoma neurosphere cells. Oncogene. 2017;36:263\u201374.","journal-title":"Oncogene."},{"key":"2304_CR15","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1128\/EC.00133-07","volume":"6","author":"DA Pasternack","year":"2007","unstructured":"Pasternack DA, Sayegh J, Clarke S, Read LK. Evolutionarily divergent type II protein arginine methyltransferase in Trypanosoma brucei. Eukaryot Cell. 2007;6:1665\u201381.","journal-title":"Eukaryot Cell"},{"key":"2304_CR16","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1210\/me.2011-1162","volume":"26","author":"SE LeBlanc","year":"2012","unstructured":"LeBlanc SE, Konda S, Wu Q, Hu YJ, Oslowski CM, Sif S, et al. Protein arginine methyltransferase 5 (Prmt5) promotes gene expression of peroxisome proliferator-activated receptor \u03b32 (PPAR\u03b32) and its target genes during adipogenesis. Mol Endocrinol. 2012;26:583\u201397.","journal-title":"Mol Endocrinol"},{"key":"2304_CR17","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1158\/0008-5472.CAN-15-1766","volume":"76","author":"L Liu","year":"2016","unstructured":"Liu L, Zhao X, Zhao L, Li J, Yang H, Zhu Z, et al. Arginine methylation of SREBP1a via PRMT5 promotes de novo lipogenesis and tumor growth. Cancer Res. 2016;76:1260\u201372.","journal-title":"Cancer Res"},{"key":"2304_CR18","doi-asserted-by":"crossref","first-page":"11031","DOI":"10.1038\/srep11031","volume":"5","author":"Y Wang","year":"2015","unstructured":"Wang Y, Zhu T, Li Q, Liu C, Han F, Chen M, et al. Prmt5 is required for germ cell survival during spermatogenesis in mice. Sci Rep. 2015;5:11031.","journal-title":"Sci Rep"},{"key":"2304_CR19","doi-asserted-by":"crossref","first-page":"9429","DOI":"10.1021\/acs.jmedchem.8b00598","volume":"61","author":"Y Wang","year":"2018","unstructured":"Wang Y, Hu W, Yuan Y. Protein arginine methyltransferase 5 (PRMT5) as an anticancer target and its inhibitor discovery. J Med Chem. 2018;61:9429\u201341.","journal-title":"J Med Chem"},{"key":"2304_CR20","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/ijc.25366","volume":"128","author":"M Yoshimatsu","year":"2011","unstructured":"Yoshimatsu M, Toyokawa G, Hayami S, Unoki M, Tsunoda T, Field HI, et al. Dysregulation of PRMT1 and PRMT6, type I arginine methyltransferases, is involved in various types of human cancers. Int J Cancer. 2011;128:562\u201373.","journal-title":"Int J Cancer"},{"key":"2304_CR21","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.tibs.2011.09.001","volume":"36","author":"V Karkhanis","year":"2011","unstructured":"Karkhanis V, Hu YJ, Baiocchi RA, Imbalzano AN, Sif S. Versatility of PRMT5-induced methylation in growth control and development. Trends Biochem Sci. 2011;36:633\u201341.","journal-title":"Trends Biochem Sci"},{"key":"2304_CR22","doi-asserted-by":"crossref","first-page":"4608","DOI":"10.1242\/dev.140715","volume":"143","author":"JL Norrie","year":"2016","unstructured":"Norrie JL, Li Q, Co S, Huang BL, Ding D, Uy JC, et al. PRMT5 is essential for the maintenance of chondrogenic progenitor cells in the limb bud. Development. 2016;143:4608\u201319.","journal-title":"Development."},{"key":"2304_CR23","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1128\/MCB.05977-11","volume":"32","author":"S Bandyopadhyay","year":"2012","unstructured":"Bandyopadhyay S, Harris DP, Adams GN, Lause GE, McHugh A, Tillmaand EG, et al. HOXA9 methylation by PRMT5 is essential for endothelial cell expression of leukocyte adhesion molecules. Mol Cell Biol. 2012;32:1202\u201313.","journal-title":"Mol Cell Biol"},{"key":"2304_CR24","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/jcmm.13020","volume":"21","author":"D Chen","year":"2017","unstructured":"Chen D, Zeng S, Huang M, Xu H, Liang L, Yang X. Role of protein arginine methyltransferase 5 in inflammation and migration of fibroblast-like synoviocytes in rheumatoid arthritis. J Cell Mol Med. 2017;21:781\u201390.","journal-title":"J Cell Mol Med"},{"key":"2304_CR25","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1158\/1541-7786.MCR-08-0197","volume":"7","author":"H Tanaka","year":"2009","unstructured":"Tanaka H, Hoshikawa Y, Oh-hara T, Koike S, Naito M, Noda T, et al. PRMT5, a novel TRAIL receptor-binding protein, inhibits TRAIL-induced apoptosis via nuclear factor-kappaB activation. Mol Cancer Res. 2009;7:557\u201369.","journal-title":"Mol Cancer Res"},{"key":"2304_CR26","doi-asserted-by":"crossref","first-page":"13516","DOI":"10.1073\/pnas.1311784110","volume":"110","author":"H Wei","year":"2013","unstructured":"Wei H, Wang B, Miyagi M, She Y, Gopalan B, Huang DB, et al. PRMT5 dimethylates R30 of the p65 subunit to activate NF-\u03baB. Proc Natl Acad Sci U S A. 2013;110:13516\u201321.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2304_CR27","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/leu.2017.334","volume":"32","author":"A Gulla","year":"2018","unstructured":"Gulla A, Hideshima T, Bianchi G, Fulciniti M, Kemal Samur M, Qi J, et al. Protein arginine methyltransferase 5 has prognostic relevance and is a druggable target in multiple myeloma. Leukemia. 2018;32:996\u20131002.","journal-title":"Leukemia."},{"key":"2304_CR28","volume":"11","author":"DP Harris","year":"2016","unstructured":"Harris DP, Chandrasekharan UM, Bandyopadhyay S, Willard B, DiCorleto PE. PRMT5-mediated methylation of NF-\u03baB p65 at Arg174 is required for endothelial CXCL11 gene induction in response to TNF-\u03b1 and IFN-\u03b3 costimulation. PLoS One. 2016;11:e0148905.","journal-title":"PLoS One"},{"key":"2304_CR29","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.joca.2007.03.006","volume":"15","author":"SS Glasson","year":"2007","unstructured":"Glasson SS, Blanchet TJ, Morris EA. The surgical destabilization of the medial meniscus (DMM) model of osteoarthritis in the 129\/SvEv mouse. Osteoarthr Cartil. 2007;15:1061\u20139.","journal-title":"Osteoarthr Cartil"},{"key":"2304_CR30","doi-asserted-by":"crossref","unstructured":"Glasson SS, Chambers MG, Van Den Berg WB and Little CB. The OARSI histopathology initiative recommendations for histological assessments of osteoarthritis in the mouse. Osteoarthritis Cartilage. 2010;null (undefined):S17\u201323.","DOI":"10.1016\/j.joca.2010.05.025"},{"key":"2304_CR31","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.joca.2015.01.016","volume":"23","author":"GW Kim","year":"2015","unstructured":"Kim GW, Han MS, Park HR, Lee EJ, Jung YK, Usmani SE, et al. CXC chemokine ligand 12a enhances chondrocyte proliferation and maturation during endochondral bone formation. Osteoarthr Cartil. 2015;23:966\u201374.","journal-title":"Osteoarthr Cartil"},{"key":"2304_CR32","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1038\/s41598-018-21184-5","volume":"8","author":"H Fang","year":"2018","unstructured":"Fang H, Huang L, Welch I, Norley C, Holdsworth DW, Beier F, et al. Early changes of articular cartilage and subchondral bone in the DMM mouse model of osteoarthritis. Sci Rep. 2018;8:2855.","journal-title":"Sci Rep"},{"key":"2304_CR33","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/jor.23608","volume":"36","author":"T Okura","year":"2018","unstructured":"Okura T, Matsushita M, Mishima K, Esaki R, Seki T, Ishiguro N, et al. Activated FGFR3 prevents subchondral bone sclerosis during the development of osteoarthritis in transgenic mice with achondroplasia. J Orthop Res. 2018;36:300\u20138.","journal-title":"J Orthop Res"},{"key":"2304_CR34","doi-asserted-by":"crossref","unstructured":"Kloppenburg M, Berenbaum F. Osteoarthritis year in review 2019: epidemiology and therapy. Osteoarthr Cartil. 2020;28:242\u20138.","DOI":"10.1016\/j.joca.2020.01.002"},{"key":"2304_CR35","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.celrep.2015.02.038","volume":"10","author":"T Onikubo","year":"2015","unstructured":"Onikubo T, Nicklay JJ, Xing L, Warren C, Anson B, Wang WL, et al. Developmentally regulated post-translational modification of nucleoplasmin controls histone sequestration and deposition. Cell Rep. 2015;10:1735\u201348.","journal-title":"Cell Rep"},{"key":"2304_CR36","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.molcel.2016.11.003","volume":"65","author":"RS Blanc","year":"2017","unstructured":"Blanc RS, Richard S. Arginine methylation: the coming of age. Mol Cell. 2017;65:8\u201324.","journal-title":"Mol Cell"},{"key":"2304_CR37","doi-asserted-by":"crossref","unstructured":"Inhibition of SDF-1\u03b1\/CXCR4 signalling in subchondral bone attenuates post-traumatic osteoarthritis. Int J Mol Sci. 2016;17:943.","DOI":"10.3390\/ijms17060943"},{"key":"2304_CR38","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s13075-018-1660-6","volume":"20","author":"Y Chen","year":"2018","unstructured":"Chen Y, Zhang D, Ho KW, Lin S, Suen WC, Zhang H, et al. GPR120 is an important inflammatory regulator in the development of osteoarthritis. Arthritis Res Ther. 2018;20:163.","journal-title":"Arthritis Res Ther"},{"key":"2304_CR39","doi-asserted-by":"crossref","first-page":"16028","DOI":"10.1038\/boneres.2016.28","volume":"4","author":"DM Findlay","year":"2016","unstructured":"Findlay DM, Kuliwaba JS. Bone-cartilage crosstalk: a conversation for understanding osteoarthritis. Bone Res. 2016;4:16028.","journal-title":"Bone Res."},{"key":"2304_CR40","doi-asserted-by":"crossref","first-page":"8452","DOI":"10.1111\/jcmm.15404","volume":"24","author":"C Pang","year":"2020","unstructured":"Pang C, Wen L, Qin H, Zhu B, Lu X, Luo S. Sotrastaurin, a PKC inhibitor, attenuates RANKL-induced bone resorption and attenuates osteochondral pathologies associated with the development of OA. J Cell Mol Med. 2020;24:8452\u201365.","journal-title":"J Cell Mol Med"},{"key":"2304_CR41","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s00264-020-04497-x","volume":"44","author":"TR Wang","year":"2020","unstructured":"Wang TR, Wang HD, Chen W, Yu TB, Qin Y, Zhang YZ. Proximal fibular osteotomy alleviates medial compartment knee osteoarthritis in a mouse model. Int Orthop. 2020;44:1107\u201313.","journal-title":"Int Orthop"},{"key":"2304_CR42","doi-asserted-by":"crossref","first-page":"110144","DOI":"10.1016\/j.biopha.2020.110144","volume":"127","author":"B Liu","year":"2020","unstructured":"Liu B, Ji C, Shao Y, Liang T, He J, Jiang H, et al. Etoricoxib decreases subchondral bone mass and attenuates biomechanical properties at the early stage of osteoarthritis in a mouse model. Biomed Pharmacother. 2020;127:110144.","journal-title":"Biomed Pharmacother"},{"key":"2304_CR43","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.cellsig.2017.03.004","volume":"34","author":"Y Dong","year":"2017","unstructured":"Dong Y, Song C, Wang Y, Lei Z, Xu F, Guan H, et al. Inhibition of PRMT5 suppresses osteoclast differentiation and partially protects against ovariectomy-induced bone loss through downregulation of CXCL10 and RSAD2. Cell Signal. 2017;34:55\u201365.","journal-title":"Cell Signal"},{"key":"2304_CR44","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.joca.2015.05.014","volume":"23","author":"O Maas","year":"2015","unstructured":"Maas O, Joseph GB, Sommer G, Wild D, Kretzschmar M. Association between cartilage degeneration and subchondral bone remodeling in patients with knee osteoarthritis comparing MRI and (99m) Tc-DPD-SPECT\/CT. Osteoarthr Cartil. 2015;23:1713\u201320.","journal-title":"Osteoarthr Cartil"},{"key":"2304_CR45","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41413-020-0100-9","volume":"8","author":"Z Ni","year":"2020","unstructured":"Ni Z, Zhou S, Li S, Kuang L, Chen H, Luo X, et al. Exosomes: roles and therapeutic potential in osteoarthritis. Bone Res. 2020;8:25.","journal-title":"Bone Res"},{"key":"2304_CR46","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1016\/j.biocel.2013.08.018","volume":"45","author":"S Rigoglou","year":"2013","unstructured":"Rigoglou S, Papavassiliou AG. The NF-\u03baB signalling pathway in osteoarthritis. Int J Biochem Cell Biol. 2013;45:2580\u20134.","journal-title":"Int J Biochem Cell Biol"},{"key":"2304_CR47","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ydbio.2019.08.012","volume":"456","author":"J Ramachandran","year":"2019","unstructured":"Ramachandran J, Liu Z, Gray RS, Vokes SA. PRMT5 is necessary to form distinct cartilage identities in the knee and long bone. Dev Biol. 2019;456:154\u201363.","journal-title":"Dev Biol"},{"key":"2304_CR48","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.joca.2019.02.797","volume":"27","author":"M Sun","year":"2019","unstructured":"Sun M, Hussain S, Hu Y, Yan J, Min Z, Lan X, et al. Maintenance of SOX9 stability and ECM homeostasis by selenium-sensitive PRMT5 in cartilage. Osteoarthr Cartil. 2019;27:932\u201344.","journal-title":"Osteoarthr Cartil"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-020-02304-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-020-02304-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-020-02304-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T05:30:43Z","timestamp":1723527043000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-020-02304-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,4]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2304"],"URL":"https:\/\/doi.org\/10.1186\/s13075-020-02304-x","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,4]]},"assertion":[{"value":"29 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The animal study in this research was approved by the Institutional Animal Care and Use Committee (IACUC) at the People\u2019s Hospital of Zhengzhou University (approval no. 2018526). The clinical specimen study was approved by the People\u2019s Hospital of Zhengzhou University Clinical Research Ethics Committee (approval no. 2017237), and informed consent was obtained from each donor.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no competing interests to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"201"}}